Life Sciences

FDA warns pharma companies for online ads

Pharma Compliance Alert, April 8, 2009

Fourteen pharmaceutical companies received warning letters from the FDA for “misleading” sponsored links on internet browsers.

The sponsored links are misleading because they make representations and/or suggestions about the efficacy of the products, but fail to communicate any risk information, according to the FDA letters.

GlaxoSmithKline, Forest Laboratories, Bayer, Cephalon, Pfizer, Novartis, Genentech, Boehringer Ingelheim, Merck, Eli Lilly, and Roche received warning letters for more than one product. Johnson & Johnson, Biogen Idec, and sanofi-aventis received warning letters for one product each. The FDA cited ads for a total of 48 products in the warning letters.

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Medical Environment Update

    A subscription to Medical Environment Update pays for itself by saving you time sorting through complex regulations and...

  • Bloodborne Pathogens Training Video

    Meets OSHA requirements for training employees on the bloodborne pathogens standard!

  • Healthcare Marketing Advisor

    Healthcare Marketing Advisor provides concise, time-saving strategies for branding, promoting, and advertising your...

  • Needlestick Prevention Training Video

    Highlighting the five most frequent needlestick scenarios, this training video instructs frontline healthcare staff on on...

Most Popular